FDA label 25663adc-777b-4368-a43c-e978b453e2d8

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
688ff095-e325-4f48-b149-e8670d9b37bc
SPL ID
25663adc-777b-4368-a43c-e978b453e2d8
Version
8
Effective date
2024-04-23
Source export date
2026-09-28
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:52:44

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 3 matching rows.

adverse reactions

ADVERSE REACTIONS The nature and frequency of adverse experiences were similar across all groups. The following tables provide comprehensive listings of the adverse experiences reported that occurred with a 5% incidence level: GALLSTONE DISSOLUTION Ursodiol Placebo 8 - 10 mg/kg/day (N=155) (N=159) N (%) N (%) Body as a Whole Allergy 8 (5.2) 7 (4.4) Chest Pain 5 (3.2) 10 (6.3) Fatigue 7 (4.5) 8 (5.0) Infection Viral 30 (19.4) 41 (25.8) Digestive System Abdominal Pain 67 (43.2) 70 (44.0) Cholecystitis 8 (5.2) 7 (4.4) Constipation 15 (9.7) 14 (8.8) Diarrhea 42 (27.1) 34 (21.4) Dyspepsia 26 (16.8) 18 (11.3) Flatulence 12 (7.7) 12 (7.5) Gastrointestinal Disorder 6 (3.9) 8 (5.0) Nausea 22 (14.2) 27 (17.0) Vomiting 15 (9.7) 11 (6.9) Musculoskeletal System Arthralgia 12 (7.7) 24 (15.1) Arthritis 9 (5.8) 4 (2.5) Back Pain 11 (7.1) 18 (11.3) Myalgia 9 (5.8) 9 (5.7) Nervous System Headache 28 (18.1) 34 (21.4) Insomnia 3 (1.9) 8 (5.0) Respiratory System Bronchitis 10 (6.5) 6 (3.8) Coughing 11 (7.1) 7 (4.4) Pharyngitis 13 (8.4) 5 (3.1) Rhinitis 8 (5.2) 11 (6.9) Sinusitis 17 (11.0) 18 (11.3) Upper Respiratory Tract Infection 24 (15.5) 21 (13.2) Urogenital System Urinary Tract Infection 10 (6.5) 7 (4.4) GALLSTONE PREVENTION Ursodiol Placebo 600 mg (N=322) (N=325) N (%) N (%) Body as a Whole Fatigue 25 (7.8) 33 (10.2) Infection Viral 29 (9.0) 29 (8.9) Influenza-like Symptoms 21 (6.5) 19 (5.8) Digestive System Abdominal Pain 20 (6.2) 39 (12.0) Constipation 85 (26.4) 72 (22.2) Diarrhea 81 (25.2) 68 (20.9) Flatulence 15 (4.7) 24 (7.4) Nausea 56 (17.4) 43 (13.2) Vomiting 44 (13.7) 44 (13.5) Musculoskeletal System Back Pain 38 (11.8) 21 (6.5) Musculoskeletal Pain 19 (5.9) 15 (4.6) Nervous System Dizziness 53 (16.5) 42 (12.9) Headache 80 (24.8) 78 (24.0) Respiratory System Pharyngitis 10 (3.1) 19 (5.8) Sinusitis 17 (5.3) 18 (5.5) Upper Respiratory Tract Infection 40 (12.4) 35 (10.8) Skin and Appendages Alopecia 17 (5.3) 8 (2.5) Urogenital System Dysmenorrhea 18 (5.6) 19 (5.8)

adverse reactions table

<table width="90%"><caption>GALLSTONE DISSOLUTION</caption><col width="50%" align="left" valign="bottom"/><col width="12%" align="center" valign="bottom"/><col width="13%" align="center" valign="bottom"/><col width="12%" align="center" valign="bottom"/><col width="13%" align="center" valign="bottom"/><thead><tr><th/><th colspan="2"><content styleCode="underline">Ursodiol</content></th><th colspan="2"><content styleCode="underline">Placebo</content></th></tr><tr><th/><th colspan="2">8 - 10 mg/kg/day (N=155)</th><th colspan="2">(N=159)</th></tr><tr><th/><th>N</th><th>(%)</th><th>N</th><th>(%)</th></tr></thead><tbody><tr><td><content styleCode="bold underline">Body as a Whole</content></td><td/><td/><td/><td/></tr><tr><td> Allergy</td><td>8</td><td>(5.2)</td><td>7</td><td>(4.4)</td></tr><tr><td> Chest Pain</td><td>5</td><td>(3.2)</td><td>10</td><td>(6.3)</td></tr><tr><td> Fatigue</td><td>7</td><td>(4.5)</td><td>8</td><td>(5.0)</td></tr><tr><td> Infection Viral</td><td>30</td><td>(19.4)</td><td>41</td><td>(25.8)</td></tr><tr><td><content styleCode="bold underline">Digestive System</content></td><td/><td/><td/><td/></tr><tr><td> Abdominal Pain</td><td>67</td><td>(43.2)</td><td>70</td><td>(44.0)</td></tr><tr><td> Cholecystitis</td><td>8</td><td>(5.2)</td><td>7</td><td>(4.4)</td></tr><tr><td> Constipation</td><td>15</td><td>(9.7)</td><td>14</td><td>(8.8)</td></tr><tr><td> Diarrhea</td><td>42</td><td>(27.1)</td><td>34</td><td>(21.4)</td></tr><tr><td> Dyspepsia</td><td>26</td><td>(16.8)</td><td>18</td><td>(11.3)</td></tr><tr><td> Flatulence</td><td>12</td><td>(7.7)</td><td>12</td><td>(7.5)</td></tr><tr><td> Gastrointestinal Disorder</td><td>6</td><td>(3.9)</td><td>8</td><td>(5.0)</td></tr><tr><td> Nausea</td><td>22</td><td>(14.2)</td><td>27</td><td>(17.0)</td></tr><tr><td> Vomiting</td><td>15</td><td>(9.7)</td><td>11</td><td>(6.9)</td></tr><tr><td><content styleCode="bold underline">Musculoskeletal System</content></td><td/><td/><td/><td/></tr><tr><td> Arthralgia</td><td>12</td><td>(7.7)</td><td>24</td><td>(15.1)</td></tr><tr><td> Arthritis</td><td>9</td><td>(5.8)</td><td>4</td><td>(2.5)</td></tr><tr><td> Back Pain</td><td>11</td><td>(7.1)</td><td>18</td><td>(11.3)</td></tr><tr><td> Myalgia</td><td>9</td><td>(5.8)</td><td>9</td><td>(5.7)</td></tr><tr><td><content styleCode="bold underline">Nervous System</content></td><td/><td/><td/><td/></tr><tr><td> Headache</td><td>28</td><td>(18.1)</td><td>34</td><td>(21.4)</td></tr><tr><td> Insomnia</td><td>3</td><td>(1.9)</td><td>8</td><td>(5.0)</td></tr><tr><td><content styleCode="bold underline">Respiratory System</content></td><td/><td/><td/><td/></tr><tr><td> Bronchitis</td><td>10</td><td>(6.5)</td><td>6</td><td>(3.8)</td></tr><tr><td> Coughing</td><td>11</td><td>(7.1)</td><td>7</td><td>(4.4)</td></tr><tr><td> Pharyngitis</td><td>13</td><td>(8.4)</td><td>5</td><td>(3.1)</td></tr><tr><td> Rhinitis</td><td>8</td><td>(5.2)</td><td>11</td><td>(6.9)</td></tr><tr><td> Sinusitis</td><td>17</td><td>(11.0)</td><td>18</td><td>(11.3)</td></tr><tr><td> Upper Respiratory Tract Infection</td><td>24</td><td>(15.5)</td><td>21</td><td>(13.2)</td></tr><tr><td><content styleCode="bold underline">Urogenital System</content></td><td/><td/><td/><td/></tr><tr><td>Urinary Tract Infection</td><td>10</td><td>(6.5)</td><td>7</td><td>(4.4)</td></tr></tbody></table>

adverse reactions table

<table width="90%"><caption>GALLSTONE PREVENTION</caption><col width="50%" align="left" valign="bottom"/><col width="12%" align="center" valign="bottom"/><col width="13%" align="center" valign="bottom"/><col width="12%" align="center" valign="bottom"/><col width="13%" align="center" valign="bottom"/><thead><tr><th/><th colspan="2"><content styleCode="underline">Ursodiol</content></th><th colspan="2"><content styleCode="underline">Placebo</content></th></tr><tr><th/><th colspan="2">600 mg (N=322)</th><th colspan="2">(N=325)</th></tr><tr><th/><th>N</th><th>(%)</th><th>N</th><th>(%)</th></tr></thead><tbody><tr><td><content styleCode="bold underline">Body as a Whole</content></td><td/><td/><td/><td/></tr><tr><td> Fatigue</td><td>25</td><td>(7.8)</td><td>33</td><td>(10.2)</td></tr><tr><td> Infection Viral</td><td>29</td><td>(9.0)</td><td>29</td><td>(8.9)</td></tr><tr><td> Influenza-like Symptoms</td><td>21</td><td>(6.5)</td><td>19</td><td>(5.8)</td></tr><tr><td><content styleCode="bold underline">Digestive System</content></td><td/><td/><td/><td/></tr><tr><td> Abdominal Pain</td><td>20</td><td>(6.2)</td><td>39</td><td>(12.0)</td></tr><tr><td> Constipation</td><td>85</td><td>(26.4)</td><td>72</td><td>(22.2)</td></tr><tr><td> Diarrhea</td><td>81</td><td>(25.2)</td><td>68</td><td>(20.9)</td></tr><tr><td> Flatulence</td><td>15</td><td>(4.7)</td><td>24</td><td>(7.4)</td></tr><tr><td> Nausea</td><td>56</td><td>(17.4)</td><td>43</td><td>(13.2)</td></tr><tr><td> Vomiting</td><td>44</td><td>(13.7)</td><td>44</td><td>(13.5)</td></tr><tr><td><content styleCode="bold underline">Musculoskeletal System</content></td><td/><td/><td/><td/></tr><tr><td> Back Pain</td><td>38</td><td>(11.8)</td><td>21</td><td>(6.5)</td></tr><tr><td> Musculoskeletal Pain</td><td>19</td><td>(5.9)</td><td>15</td><td>(4.6)</td></tr><tr><td><content styleCode="bold underline">Nervous System</content></td><td/><td/><td/><td/></tr><tr><td> Dizziness</td><td>53</td><td>(16.5)</td><td>42</td><td>(12.9)</td></tr><tr><td> Headache</td><td>80</td><td>(24.8)</td><td>78</td><td>(24.0)</td></tr><tr><td><content styleCode="bold underline">Respiratory System</content></td><td/><td/><td/><td/></tr><tr><td> Pharyngitis</td><td>10</td><td>(3.1)</td><td>19</td><td>(5.8)</td></tr><tr><td> Sinusitis</td><td>17</td><td>(5.3)</td><td>18</td><td>(5.5)</td></tr><tr><td> Upper Respiratory Tract Infection</td><td>40</td><td>(12.4)</td><td>35</td><td>(10.8)</td></tr><tr><td><content styleCode="bold underline">Skin and Appendages</content></td><td/><td/><td/><td/></tr><tr><td> Alopecia</td><td>17</td><td>(5.3)</td><td>8</td><td>(2.5)</td></tr><tr><td><content styleCode="bold underline">Urogenital System</content></td><td/><td/><td/><td/></tr><tr><td> Dysmenorrhea</td><td>18</td><td>(5.6)</td><td>19</td><td>(5.8)</td></tr></tbody></table>

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.